Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
aim, aminopeptidase, AstraZeneca, beloranib, biosimilar, Boehringer, book, brain, captionedJasin, caseen, clock, compatible, contending, Council, crowded, CTA, dapagliflozin, deferral, dialog, distort, empagliflozin, encourage, Endo, endorsement, Farxiga, filer, FL, GLP, Glyxambi, GMP, heavy, HTA, hunger, ICH, Ingelheim, installment, intangible, irrespective, Jan, Jane, Jardiance, Jasin, Maestro, Mary, Memorandum, methionine, Mezzion, misrepresented, movement, nerve, noncancelable, Orange, orphan, petition, PIP, Qudexy, Rechargeable, rehear, remainingJasin, Saxenda, sequestration, slated, SmPC, sNDA, societal, Squibb, staffing, stomach, sublessee, sue, Transparency, transparent, unspecified, unutilized, usage, useable, Zafgen
Filing tables
Filing exhibits
Related press release
VVUS similar filings
Filing view
External links